Curcumin-shellac nanoparticle-loaded GelMA/SilMA hydrogel for colorectal cancer therapy
European Journal of Pharmaceutics and Biopharmaceutics · 2024
DOI: 10.1016/j.ejpb.2024.114409 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2024. Verfasst von Bo Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Changzhou University, Changzhou 213164, China. Hauptthemen laut MEDLINE: Curcumin, Colorectal Neoplasms, Nanoparticles, Gelatin. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: NSFC, Jiangsu Province Department of Education.
Abstract (Originalsprache)
In this study, a novel approach was employed to develop a therapeutic system for colorectal cancer treatment. Specifically, a GelMA/SilMA hydrogel loaded with curcumin-shellac nanoparticles (Cur@Lac NPs) was created. A microfluidic swirl mixer was utilized to formulate stable Cur@Lac NPs, ensuring their consistent and effective encapsulation. The pH-specific release of curcumin from the NPs demonstrated their potential for colon cancer treatment. By carefully regulating the ratio of GelMA (gelatin methacrylate) and SilMA (silk fibroin methacrylate), a GelMA/SilMA dual network hydrogel was generated, offering controlled release and degradation capabilities. The incorporation of SilMA notably enhanced the mechanical properties of the dual network matrix, improving compression resistance and mitigating deformation. This mechanical improvement is crucial for maintaining the structural integrity of the hydrogel during in vivo applications. In comparison to the direct incubation of curcumin, the strategy of encapsulating curcumin into NPs and embedding them within the GelMA/SilMA hydrogel resulted in more controlled release mechanisms. This controlled release was achieved through the disintegration of the NPs and the swelling and degradation of the hydrogel matrix. The encapsulating strategy also demonstrated enhanced cellular uptake of curcumin, leveraging the advantages of both NPs and in-situ hydrogel injection. This combination ensures a more efficient and sustained delivery of the therapeutic agent directly to the tumor site. Overall, this approach holds significant promise as a smart drug delivery system, potentially improving the efficacy of colorectal cancer treatments by providing targeted, controlled, and sustained drug release with enhanced mechanical stability and biocompatibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Changzhou University, Changzhou 213164, China.
- Department of Pharmacy, Wujin Hospital Affiliated with Jiangsu University, Changzhou 213000, China; The Wujin Clinical College of Xuzhou Medical University, Changzhou, Jiangsu, China.
- Jinhua Advanced Research Institute, Jinhua 321019, China.
- School of Pharmacy, Changzhou University, Changzhou 213164, China. Electronic address: xiubo.zhao@cczu.edu.cn.
Förderung
- NSFC
- Jiangsu Province Department of Education
Zitieren
APA
Zhang, B., Yan, J., Jin, Y., Yang, Y., & Zhao, X. (2024). Curcumin-shellac nanoparticle-loaded GelMA/SilMA hydrogel for colorectal cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2024.114409
Vancouver
Zhang B, Yan J, Jin Y, Yang Y, Zhao X. Curcumin-shellac nanoparticle-loaded GelMA/SilMA hydrogel for colorectal cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics. 2024. doi:10.1016/j.ejpb.2024.114409
BibTeX
@article{Zhang2024,
author = {Zhang, Bo and Yan, Jiaxuan and Jin, Yi and Yang, Yushun and Zhao, Xiubo},
title = {Curcumin-shellac nanoparticle-loaded GelMA/SilMA hydrogel for colorectal cancer therapy},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2024},
doi = {10.1016/j.ejpb.2024.114409}
}
EUVIMED